Saturday , 8 February 2025
Home Pharmaceutical Industry

Pharmaceutical Industry

Billionairesworld's billionaires

Legacy and Leadership: How Tse Ping & Family Continue to Shape the Global Pharmaceutical Industry

As of January 2025, the Tse family continues to be a prominent force in the pharmaceutical industry, with significant developments marking their recent...

Billionairesworld's billionaires

Peter Gassner: Pioneering the Future of Cloud Software in Life Sciences

Peter Gassner, born in 1965, is a distinguished American entrepreneur renowned for his significant contributions to the software industry, particularly within the life...

Billionairesworld's billionaires

Stéphane Bancel: Leading Moderna’s Evolution and Innovation

Stéphane Bancel, born on July 20, 1972, in Marseille, France, has emerged as a pivotal figure in the biotechnology sector. Currently serving as...

Billionairesworld's billionaires

Egor Kulkov: The Reclusive Architect of Russia’s Pharmaceutical Empire

Egor Nikolaevich Kulkov, born on December 7, 1971, in Novosibirsk, Russia, is a prominent yet enigmatic figure in the global pharmaceutical industry. With...

Media

Johnson & Johnson Acquires Intra-Cellular Therapies for $14.6 Billion, Expanding Mental Health Portfolio

In a significant move that reshapes the landscape of mental health therapeutics, Johnson & Johnson (NYSE: JNJ) announced today its acquisition of Intra-Cellular...

Media

Moderna Stock Plunges as Company Slashes 2025 Revenue Forecast and Announces Major Cost Cuts

Moderna (NASDAQ: MRNA) shares tumbled 18% in premarket trading on Monday after the biotechnology company significantly lowered its 2025 revenue forecast and announced...

Media

Walgreens Surges 27% as Cost-Cutting Measures and Strong Q1 Performance Signal Turnaround

In a remarkable turnaround for the pharmacy retail giant, Walgreens Boots Alliance shares skyrocketed 27% following the announcement of better-than-expected first-quarter earnings for...

Media

GSK Makes Strategic $1.15 Billion Move to Acquire IDRx, Strengthening Its Cancer Treatment Portfolio

British pharmaceutical giant GSK has announced its agreement to acquire Boston-based biotechnology firm IDRx for up to $1.15 billion, marking a significant expansion...

Media

Fargo’s Biotech Hub Sees Mixed Fortunes as Aldevron Announces Layoffs Amid Broader Industry Growth

In a significant development for Fargo’s burgeoning biotech sector, industry leader Aldevron has announced a 5% reduction in its workforce this week, marking...

Billionairesworld's billionaires

The Life and Legacy of Maurizio Billi

Maurizio Billi stands as a prominent figure in the global pharmaceutical industry, renowned for his leadership and strategic foresight in expanding Eurofarma into...